Evaluation of the Effectiveness of Dentin Hypersensitivity Treatment Using Glass Ionomer Cements: A Randomized Clinical Trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 主要终点
- Pain Scores as measured by the Visual Analog Scale (VAS)
研究概览
简要总结
The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.
详细描述
Subjects will require to have at least two teeth in different hemiarchs with dentin hypersensitivity. Teeth will be randomized into 2 groups, receiving either Clinpro XT or the conventional glass ionomer cement Vidrion R. Prior to the desensitizing treatment (baseline), painful symptoms will be assessed by tactile and air blast tests using the Visual Analogue Scale (VAS). Treatment evaluations will be conducted up to 2-year post-treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 28 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male and female subjects between 18 and 70 years old
- •At least 2 teeth with dentin hypersensitivity in two different hemiarchs
- •Dental elements with hypersensitivity without any pulp alteration
- •People who are not taking any medication and women who are not pregnant
- •Patients without eating disorders or very acidic diets.
排除标准
- •Teeth with hypersensitivity that presented extensive or unsatisfactory restorations, fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic treatments, pulp alterations.
- •Subjects who received any desensitizing therapy during the last 3 months
- •Subjects being under analgesics/anti-inflammatory drugs at the time of the study
- •Teeth with hypersensitivity and non-carious cervical lesions
研究组 & 干预措施
Clinpro XT (3M ESPE, Minnesota, USA)
Resin-modified glass ionomer cement
干预措施: Resin-modified glass ionomer cement Clinpro XT (Drug)
Vidrion R (SS White, Gloucester, UK)
Conventional glass ionomer cement
干预措施: Glass Ionomer cement Vidrion R (Drug)
结局指标
主要结局
Pain Scores as measured by the Visual Analog Scale (VAS)
时间窗: Change from Baseline in Pain Scores at 20 minutes; at 7, 15, 21, 30 days; and after 3, 6, 12, 24 months.
Tactile and air blast tests to evaluate pain with VAS
次要结局
未报告次要终点
研究者
Rafael Guerra Lund
Associate Professor
Federal University of Pelotas